Products

A completely new category of lenses that utilize a clear lens’ inherent chromatic aberration in a positive way to increase retinal dopamine which results in a thicker choroid and a stronger sclera. Both of which increase the strength of the eye’s ocular structure to offset part or all of the force causing axial elongation. DopaLens™ should increase Dopamine in the eye and possibly Dopamine and / or Serotonin in the Brain. Therefore, DopaLens™ can also be worn by patients with other types of dopamine deficiency disorders.

(QT for Quick Time) A darkened, enhanced version of DopaLens™ that is worn for brief periods of time independent of one’s conventional myopic correcting eyewear or as fit over eyewear in addition one’s conventional eyewear. DopaQT™ delivers the specific wavelengths of light (480nm +/- 30nm) required to produce dopamine in the eye’s retina and possibly Dopamine and /or Serotonin in the Brain.  For this reason, DopaQT™ may be able to be worn for minutes in the morning and mid-day to slowdown, and possibly stop myopia progression. DopaQT™ can also be worn by patients with other types of dopamine deficiency disorders.

The use of blue light (within the wavelength range of 480nm +/- 30nm) to increase retinal dopamine which then directly and indirectly results in a thicker choroid and a stronger sclera. Both of which increase the strength of the eye’s ocular structure thus offsetting part or all of the force causing axial elongation.  DopaTherapy™ can be employed prior to a child becoming myopic or after becoming myopia. DopaTherapy™ can also be employed for helping other types of dopamine disorders.

XR eyewear (AR, MR, VR), that delivers to the eye’s retina the desired wavelengths of light for the purposes of Ocular Photo-Bio-Stimulation. By way of example only, blue light wavelengths of 480nm +/- 30nm for slowing or stopping myopia progression. DopaXR™ can also be used by patients with other types of dopamine deficiency disorders.